Artificial intelligence drug discovery uses computational models to rank biological targets, predict molecular properties, design candidates or choose experiments. These tools can make established stages faster and help teams search large design spaces more efficiently.
Drug development still depends on whether the target is biologically relevant and whether an intervention is safe and effective in people. Laboratory experiments, clinical trials, regulation and organizational execution remain necessary even when model capability improves.
Acronyms and aliases
AI drug discovery acronymAI-assisted drug discovery acronymartificial intelligence drug discovery variant
General terms
Specialised terms
Related terms
Frequently asked questions
Can AI discover a drug without laboratory testing?
No. AI can propose and prioritize candidates, but laboratory and clinical evidence is required to establish biological activity, safety and effectiveness.
What parts of drug discovery can AI support?
AI can support literature analysis, target ranking, protein and molecule design, property prediction, experiment selection and interpretation of measured results.
